We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
  • SKIP TO CONTENT
  • SKIP NAVIGATION
  • Drug News
    • Trending
    • Commercial Operations
    • GMPs
    • FDA Enforcement Actions
    • Inspections and Audits
    • Postmarket Safety
    • Quality
    • Regulatory Affairs
    • Research and Development
    • Submissions and Approvals
    • FDAnews Drug Weekly
    • FDAnews
  • Device News
    • Trending
    • Commercial Operations
    • FDA Enforcement Actions
    • Inspections and Audits
    • Postmarket Safety
    • Quality
    • Regulatory Affairs
    • Research and Development
    • Submissions and Approvals
    • FDAnews Device Weekly
    • FDAnews
  • Books
    • FDAnews Books Library
    • Drug Books
    • Device Books
  • Training/Events
    • Webinar Training Pass
    • Events
  • Resources
    • Form 483s Database
    • FDA Approved Drugs
    • eCFR and Guidances
    • White Papers
  • CenterWatch
  • About Us
    • The Company
    • FDAnews Editorial Board
    • Contact Us
  • Advertising
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Store » Webinar Recordings » Precision Medicine: Challenging the Regulatory Landscape - Webinar Recording/Transcript

Other Options

Audio Recording/Transcript - May 3, 2018

$287.00

Audio Recording/Transcript - May 3, 2018

$258.00

Audio Recording/Transcript - May 3, 2018

$244.00

Audio Recording/Transcript - May 3, 2018

$230.00

Audio Recording/Transcript - May 3, 2018

$215.00

Precision Medicine: Challenging the Regulatory Landscape - Webinar Recording/Transcript

$287.00
Webinar Recordings

Product Details

Precision Medicine: Challenging the Regulatory Landscape

“Precision Medicine,” a/k/a “Personalized Medicine,” promises a new and rich path to drug and device profits. But a top Washington FDA lawyer offers a list of precautions as you take the plunge.

Kupchyk Esq., former Associate Chief Counsel for Drugs and Biologics and Assistant General Counsel for Litigation, reveals what FDA insiders are thinking as they confront this challenge to traditional regulatory structures … and how they plan to move forward.

Over the course of 90 fast-paced minutes, Ms. Kupchyk, now a top member of the Washington FDA bar, will cover:

  • Top FDA concerns: Precision medicine products, including how to ensure accuracy of next-generation sequencing tests
  • Draft guidances: Discover key points in FDA’s two pending draft guidance documents, including allowing NGS developers to use data from FDA-recognized public databases of genetic variants to help support a test's clinical validity
  • Industry blowback: The level of evidence the FDA will accept to analytically validate additional or expanded application of NGS tests
  • Pros and cons of various approaches, including implications of  binding or non-binding recommendations
  • What’s been approved : A look at FoundationOne CDx (F1CDx), the first breakthrough-designated NGS-based IVD test (it claims to detect genetic mutations in 324 genes and two genomic signatures in any solid tumor type)
  • And much more

Should you cash in on the precision medicine bonanza? By all means. Should you take appropriate regulatory precautions beforehand? But of course. This is the quick, easy, reliable way to do so.

  • Drug Products
    • Quality
    • Regulatory Affairs
    • GMPs
    • Inspections and Audits
    • Postmarket Safety
    • Submissions and Approvals
    • Research and Development
    • Commercial Operations
  • Device Products
    • Quality
    • Regulatory Affairs
    • QSR
    • Inspections and Audits
    • Postmarket Safety
    • Submissions and Approvals
    • Research and Development
    • Commercial Operations
  • Clinical Products
    • Trial Design
    • Data Integrity
    • GCP
    • Inspections and Audits
    • Transparency
  • Privacy Policy
  • Do Not Sell or Share My Data
Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 703.538.7600 – Toll free 888.838.5578

Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing